Clinical detection and equipment development of vancomycin blood concentration based on surface plasmon resonance (SPR) biosensors

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2400082610

Enrollment

Unknown

Registered

2024-04-01

Start date

2024-04-01

Completion date

Unknown

Last updated

2024-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infection

Interventions

Infection group (high-performance liquid chromatography, SPR):None

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Admitted to ICU, aged 18 years or older 2. Application of vancomycin 3. Voluntary signing of informed consent form

Exclusion criteria

Exclusion criteria: Patients whose blood drug concentration testing is affected by various reasons

Design outcomes

Primary

Measure	Time frame
Blood drug concentration of vancomycin;Blood drug concentration of vancomycin;Blood drug concentration of vancomycin;Blood drug concentration of vancomycin;	—

Secondary

Measure	Time frame
Complete blood count;;	—

Countries

China

Contacts

Public ContactRongrong Ren

Xinhua Hospital, Shanghai Jiaotong University School of Medicine

renrongrong@xinhuamed.com.cn+86 21 2507 7825

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026